Godavari Biorefineries has incorporated Sathgen Therapeutics LLC, a wholly owned step down subsidiary based in Princeton, New Jersey, USA. This strategic expansion strengthens the company’s clinical stage biotechnology presence in the United States, with a primary focus on global out-licensing of intellectual property and to build the network to accelerate the drug-development programme.
Sathgen Therapeutics has also formed a Scientific Advisory Board (SAB) to guide its clinical-development and translational-research strategy. The SAB includes Razelle Kurzrock, an internationally known authority in precision oncology, immunotherapy, and early-phase clinical trials, and Massimo Cristofanilli, a leading global expert in metastatic breast cancer and cancer biology.
Godavari Biorefineries is one of the manufacturers of ethanol-based chemicals in India. Its diversified product portfolio comprises of bio-based chemicals, sugar, different grades of ethanol and power.
